Through clinical trials, RMPDC evaluates drugs for poisoning treatment applications and orphan drug indications that involve multi-center operations, study management, data collection, data management, data analysis, and reporting. RMPDC can help with all aspects of your study from design to final reporting.
Some of our accomplishments include helping drug companies gain approvals for:
CroFab − North American crotaline snake envenomation
DigiFab − cardiac glycoside intoxications
Antizol − toxic alcohol (methanol & ethylene glycol) intoxications
Acetadote – acetaminophen intoxications
Radiogardase − thallium and radiocesium exposures
Cyanokit − cyanide exposures
Contact us to see how we can assist with your clinical research needs.